Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Ulcerative Colitis”

Showing 20 of 0 results

Not applicableLooking for participantsNCT07726888
What this trial is testing

Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (Disorder)Guselkumab
Second Affiliated Hospital of Wenzhou Medical University 97
Large-scale testing (Phase 3)Study completedNCT01863771
What this trial is testing

A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.

Who this might be right for
Colitis, Ulcerative
Janssen Pharmaceutical K.K. 144
Not applicableNot Yet RecruitingNCT07062185
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis (UC)
Tang-Du Hospital 10
Testing effectiveness (Phase 2)Study completedNCT05372939
What this trial is testing

Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)

Who this might be right for
Ulcerative Colitis
Applied Molecular Transport 51
Testing effectiveness (Phase 2)Study completedNCT05570006
What this trial is testing

Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06290934
What this trial is testing

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Gilead Sciences 228
Large-scale testing (Phase 3)Ended earlyNCT06570772
What this trial is testing

Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio

Who this might be right for
Ulcerative Colitis
Alvotech Swiss AG 301
Large-scale testing (Phase 3)Active Not RecruitingNCT03950232
What this trial is testing

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 896
Large-scale testing (Phase 3)Study completedNCT00408629
What this trial is testing

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abbott 518
Testing effectiveness (Phase 2)Active Not RecruitingNCT07035041
What this trial is testing

D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
UC - Ulcerative ColitisModerately to Severely Active Ulcerative Colitis
InventisBio Co., Ltd 120
Testing effectiveness (Phase 2)Study completedNCT00727324
What this trial is testing

Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AM-Pharma 22
Large-scale testing (Phase 3)Study completedNCT00487539
What this trial is testing

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 1,065
Testing effectiveness (Phase 2)Study completedNCT04023396
What this trial is testing

Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 217
Testing effectiveness (Phase 2)Study completedNCT02589665
What this trial is testing

Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 249
Post-approval studies (Phase 4)Ended earlyNCT02579733
What this trial is testing

Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Kyungpook National University Hospital 16
Large-scale testing (Phase 3)Active Not RecruitingNCT06589986
What this trial is testing

Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Moderately to Severely Active Ulcerative Colitis
Hoffmann-La Roche 400
Large-scale testing (Phase 3)Not Yet RecruitingNCT07650942
What this trial is testing

Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Ganzhou Hemay Pharmaceutical Co., Ltd 360
Not applicableStudy completedNCT02506179
What this trial is testing

Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 100
Large-scale testing (Phase 3)Study completedNCT02065557
What this trial is testing

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 101
Testing effectiveness (Phase 2)Looking for participantsNCT07697456
What this trial is testing

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn's DiseaseUlcerative Colitis
AbbVie 2,000
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation